SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-013743
Filing Date
2019-07-26
Accepted
2019-07-26 17:15:52
Documents
44
Period of Report
2019-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0519_bespokeextra.htm 10-Q 369199
2 CERTIFICATION f10q0519ex31-1_bespoke.htm EX-31.1 13798
3 CERTIFICATION f10q0519ex32-1_bespoke.htm EX-32.1 6046
  Complete submission text file 0001213900-19-013743.txt   2883314

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bspk-20190531.xml EX-101.INS 393692
5 XBRL SCHEMA FILE bspk-20190531.xsd EX-101.SCH 35222
6 XBRL CALCULATION FILE bspk-20190531_cal.xml EX-101.CAL 34659
7 XBRL DEFINITION FILE bspk-20190531_def.xml EX-101.DEF 155971
8 XBRL LABEL FILE bspk-20190531_lab.xml EX-101.LAB 269372
9 XBRL PRESENTATION FILE bspk-20190531_pre.xml EX-101.PRE 221191
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 19978694
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences